Chubb Limited (CB)
(Delayed Data from NYSE)
$266.64 USD
-4.18 (-1.54%)
Updated Jun 3, 2024 04:00 PM ET
After-Market: $266.65 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$266.64 USD
-4.18 (-1.54%)
Updated Jun 3, 2024 04:00 PM ET
After-Market: $266.65 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Zacks News
Chubb Limited was formerly known as ACE Limited. ACE Limited after acquiring The Chubb Corp in Jan 2016 assumed the name of Chubb. Headquartered in Zurich, Switzerland, the company boasts being one of the world’s largest providers of property and casualty (P&C) insurance and reinsurance and largest publicly traded P&C insurer, based on market capitalization of $56.9 billion. Chubb has diversified through acquisitions into many specialty lines, including marine, medical risk, excess property, environmental and terrorism insurance and has local operations in 54 countries and territories. Chubb provides specialized insurance products such as personal accident, supplemental health and life insurance to individuals in select countries. Its reinsurance operations include both P&C and life companies.
Aflac Rides on Strong U.S. Business and Solid Balance Sheet
by Zacks Equity Research
Aflac's (AFL) favorable U.S business, changes in Japan business and a strong balance sheet are likely to aid its long-term growth.
Allstate (ALL) Estimates Weather Related Losses in July
by Zacks Equity Research
Allstate (ALL) expects to incur $223 million pre-tax catastrophe loss for July, which can be attributed to 10 weather-related events.
Top Research Reports: Bristol-Myers, CME Group, Chubb & More
by Kalyan Nandy
Today's Research Daily features updated research reports on 16 major stocks, including Bristol-Myers (BMY), CME Group (CME) and Chubb (CB).
MetLife (MET) Q2 Earnings Surpass Estimates, Increase Y/Y
by Zacks Equity Research
MetLife's (MET) second-quarter earnings benefit from lower expenses, partly offset by decline in revenues.
Allstate (ALL) Beats on Q2 Earnings and Revenues, Up Y/Y
by Zacks Equity Research
Allstate's (ALL) Q2 earnings benefit from increase in premium, partly offset by catastrophe losses.
Chubb's (CB) Earnings Beat Estimates in Q2, Decrease Y/Y
by Zacks Equity Research
Chubb's (CB) second-quarter earnings gain from higher premium revenues.
Chubb (CB) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Chubb (CB) delivered earnings and revenue surprises of 0.78% and 12.14%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Why Chubb (CB) Might Surprise This Earnings Season
by Zacks Equity Research
Chubb (CB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Chubb (CB) to Report Q2 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Chubb's (CB) second quarter earnings is likely to benefit from increased scale, improved commercial property and casualty pricing and prudent underwriting.
RLI Corp.'s (RLI) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
RLI Corp.'s (RLI) Q2 results reflect improved premiums across most of its product lines along with increase in net investment income.
Travelers (TRV) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Travelers (TRV) Q2 is likely to benefit from increase in premiums, successful execution of marketplace strategies and a benign cat environment.
Progressive (PGR) Q2 Earnings Beat, Increase Year Over Year
by Zacks Equity Research
Progressive's (PGR) second quarter results reflect improvement in revenues offset the increase in expense.
Chubb (CB) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Chubb (CB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for Alliance Data (ADS) in Q2 Earnings?
by Zacks Equity Research
Alliance Data's (ADS) in Q2 earnings is likely to be impacted by improved performance at Card Service segment, though high expenses might weigh on operating margins.
Factors Likely to Influence Progressive's (PGR) Q2 Earnings
by Zacks Equity Research
Progressive's (PGR) second quarter earnings likely have been benefited from solid policies in force and competitive rates.
7 Insurers Poised for Q2 Outperformance on Multiple Tailwinds
by Tanuka De
We have identified seven insurers poised to outshine in the second quarter banking on solid fundamentals and favorable macro environment.
Why Chubb (CB) Could Beat Earnings Estimates Again
by Zacks Equity Research
Chubb (CB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Allstate (ALL) Expects to Incur Catastrophe Loss in May
by Zacks Equity Research
Being a relatively large property insurance business, Allstate (ALL) is significantly exposed to catastrophic events
Chubb or Travelers: Which P&C Insurer is Better Placed?
by Tanuka De
Given a favorable operating backdrop, let's see which stock - Chubb (CB) or Travelers (TRV) is a more viable investment option based on comparative analysis.
Chubb Rallies 15% Year to Date: What's Aiding the Stock?
by Zacks Equity Research
Chubb's (CB) operational excellence and growth initiatives help the stock continue the bull run.
W.R. Berkley Board Okays Dividend Hike and Special Dividend
by Zacks Equity Research
W.R. Berkley's (WRB) recent dividend hike and special dividend reflects operational excellence and effective capital deployment.
Chubb (CB) Up 1.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Chubb (CB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Unum (UNM) Board Approves Dividend Hike & Share Buyback
by Zacks Equity Research
Unum's (UNM) efforts to increase dividend and approve share buyback program reflect its operational strength supporting effective capital deployment.
The Zacks Analyst Blog Highlights: Chubb, Las Vegas Sands, Biogen, Dollar General and Canadian Pacific
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Chubb, Las Vegas Sands, Biogen, Dollar General and Canadian Pacific
Top Research Reports for Chubb, Las Vegas Sands & Biogen
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Chubb (CB), Las Vegas Sands (LVS) and Biogen (BIIB).